Malignant pleural mesothelioma (MPM) is an aggressive tumor strongly associated with asbestos exposure. Patients are usually diagnosed when current treatments have limited benefits, highlighting the need for noninvasive early diagnostic tests to monitor asbestos-exposed people.

Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects

Guarrera, Simonetta;Viberti, Clara;Cugliari, Giovanni;Allione, Alessandra;Casalone, Elisabetta;Casadio, Caterina;Grosso, Federica;Matullo, Giuseppe
Last
2019-01-01

Abstract

Malignant pleural mesothelioma (MPM) is an aggressive tumor strongly associated with asbestos exposure. Patients are usually diagnosed when current treatments have limited benefits, highlighting the need for noninvasive early diagnostic tests to monitor asbestos-exposed people.
2019
14
3
527
539
Asbestos exposure; Case-control discrimination; DNA-methylation; Early biomarker; Malignant pleural mesothelioma
Guarrera, Simonetta; Viberti, Clara; Cugliari, Giovanni; Allione, Alessandra; Casalone, Elisabetta; Betti, Marta; Ferrante, Daniela; Aspesi, Anna; Casadio, Caterina; Grosso, Federica; Libener, Roberta; Piccolini, Ezio; Mirabelli, Dario; Dianzani, Irma; Magnani, Corrado; Matullo, Giuseppe
File in questo prodotto:
File Dimensione Formato  
guarrera_postprint MPM-Meth_JTO_2018.pdf

Open Access dal 01/01/2020

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.28 MB
Formato Adobe PDF
1.28 MB Adobe PDF Visualizza/Apri
2019_Guarrera.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 897.98 kB
Formato Adobe PDF
897.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1693746
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 23
social impact